Age (years) |
54.9 (11.6) |
|
Education (years) |
15.7 (2.6) |
|
Self-Administered Comorbidity Questionnaire score |
4.3 (2.8) |
|
Karnofsky Performance Status score |
93.2 (10.3) |
|
|
% |
|
Non-white |
35.4 |
|
Married or partnered |
41.5 |
|
Lives alone |
24.1 |
|
Employed |
47.5 |
|
Postmenopausal |
62.3 |
|
Stage of disease |
|
0 |
18.3 |
I |
37.9 |
IIA, IIB |
35.4 |
IIIA,IIIB,IIIC,IV |
8.3 |
|
Neoadjuvant chemotherapy |
19.8 |
|
Type of surgery |
|
Breast conservation |
79.9 |
Mastectomy |
20.1 |
|
Sentinel lymph node biopsy |
82.4 |
|
Axillary node dissection |
37.4 |
|
Underwent reconstruction at time of surgery |
21.6 |
|
Received adjuvant radiation therapy in first six months |
56.6 |
|
Received adjuvant chemotherapy in the first six months |
33.6 |
|
Symptom severity scores prior to surgery |
Mean (SD) |
|
Center for Epidemiological Studies-Depression score |
13.7 (9.8) |
|
Trait Anxiety Inventory score |
35.3 (9.0) |
|
State Anxiety Inventory score |
41.8 (13.5) |
|
General Sleep Disturbance Scale score |
48.3 (21.6) |
|
Lee Fatigue Scale - Fatigue score |
3.1 (2.4) |
|
Lee Fatigue Scale - Energy score |
4.9 (2.5) |
|
Attentional Function Index score |
6.6 (1.9) |